New obesity drug combo shows promise in Mid-Stage trial
Disease control
Ongoing
This study tests a new drug called nimacimab to help people who are overweight or obese lose weight. Some participants will get nimacimab alone, some with another weight-loss drug (semaglutide), and some a placebo. The goal is to see if nimacimab is safe and effective for weight …
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated May 17, 2026 10:38 UTC